Search results
Rutherrin(R) Increases Efficacy of Chemotherapy
The Joplin Globe· 2 days agoChemotherapy...
Barinthus Bio slashes headcount by 25% and refocuses pipeline
Pharmaceutical Technology via Yahoo Finance· 1 day agocompany currently has a headcount of around 130 employees, according to GlobalData. GlobalData is...
Supreme Court rejects bid to restrict access to abortion pill
NBC News via Yahoo News· 22 hours agoIn rejecting the challenge, the court "maintained the stability of the FDA drug approval process,...
Billions at stake as national battle over drug pricing plays out in Missouri
Missouri Independent via Yahoo News· 1 day agoIn a battle that pits some of the biggest players in health care against each other, the Missouri...
USPTO Unveils Examiner Guidance on Searching Drug-related Applications | JD Supra
JD Supra· 3 days agoTo recap, in one of its first acts, the Administration...
Mold colonies and liquid-flooded air purifiers: CVS sourced medication from tainted factories—and it...
Fortune via Yahoo Finance· 3 days agoIt also completes an average of 350 daily tests to...return to hospitals for more intensive...
Siegfried to boost drug substances offering with new acquisition
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe strategic move will enhance Siegfried’s capabilities and geographical coverage...tier hub for...
Jesse Plemons Addresses Ozempic Rumors Amid Weight Loss Journey
E! News via Yahoo News· 14 hours agoBreaking Bad actor Jesse Plemons cleared the air about his weight loss, shutting down speculation...
Drug shortages hit highest number since 2001, impacting patients, hospitals and pharmacies
WPXI via Yahoo News· 3 days agoWe reached out to the Pharmaceutical Research and Manufacturers of America (PhRMA) which represents more than two dozen drug companies about these numbers ...
Billionaire Groupon Founder Eric Lefkofsky’s Health Tech Company Goes Public—His Fourth IPO
Forbes· 12 hours agoFive years ago, Chicago-based billionaire and serial entrepreneur Eric Lefkofsky told Forbes he...